Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CNXC vs IBEX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CNXC
Concentrix Corporation

Information Technology Services

TechnologyNASDAQ • US
Market Cap$1.79B
5Y Perf.-68.2%
IBEX
IBEX Limited

Information Technology Services

TechnologyNASDAQ • US
Market Cap$441M
5Y Perf.+64.6%

CNXC vs IBEX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CNXC logoCNXC
IBEX logoIBEX
IndustryInformation Technology ServicesInformation Technology Services
Market Cap$1.79B$441M
Revenue (TTM)$9.83B$627M
Net Income (TTM)$-1.28B$47M
Gross Margin33.3%21.3%
Operating Margin6.2%9.2%
Forward P/E2.2x9.6x
Total Debt$4.64B$70M
Cash & Equiv.$327M$15M

CNXC vs IBEXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CNXC
IBEX
StockNov 20May 26Return
Concentrix Corporat… (CNXC)10031.8-68.2%
IBEX Limited (IBEX)100164.6+64.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: CNXC vs IBEX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IBEX leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Concentrix Corporation is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
CNXC
Concentrix Corporation
The Income Pick

CNXC is the clearest fit if your priority is income & stability.

  • Dividend streak 5 yrs, beta 1.38, yield 5.6%
  • Lower P/E (2.2x vs 9.6x)
  • 5.6% yield; 5-year raise streak; the other pay no meaningful dividend
Best for: income & stability
IBEX
IBEX Limited
The Growth Play

IBEX carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 9.8%, EPS growth 28.3%, 3Y rev CAGR 4.2%
  • 112.7% 10Y total return vs CNXC's -61.0%
  • Lower volatility, beta 0.80, Low D/E 51.9%, current ratio 1.82x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthIBEX logoIBEX9.8% revenue growth vs CNXC's 2.2%
ValueCNXC logoCNXCLower P/E (2.2x vs 9.6x)
Quality / MarginsIBEX logoIBEX7.5% margin vs CNXC's -13.0%
Stability / SafetyIBEX logoIBEXBeta 0.80 vs CNXC's 1.38, lower leverage
DividendsCNXC logoCNXC5.6% yield; 5-year raise streak; the other pay no meaningful dividend
Momentum (1Y)IBEX logoIBEX+29.9% vs CNXC's -46.7%
Efficiency (ROA)IBEX logoIBEX16.4% ROA vs CNXC's -10.8%, ROIC 19.5% vs 5.6%

CNXC vs IBEX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CNXCConcentrix Corporation
FY 2025
Reportable Segment
100.0%$9.8B
IBEXIBEX Limited

Segment breakdown not available.

CNXC vs IBEX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIBEXLAGGINGCNXC

Income & Cash Flow (Last 12 Months)

IBEX leads this category, winning 4 of 6 comparable metrics.

CNXC is the larger business by revenue, generating $9.8B annually — 15.7x IBEX's $627M. IBEX is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, IBEX holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCNXC logoCNXCConcentrix Corpor…IBEX logoIBEXIBEX Limited
RevenueTrailing 12 months$9.8B$627M
EBITDAEarnings before interest/tax$773M$76M
Net IncomeAfter-tax profit-$1.3B$47M
Free Cash FlowCash after capex$572M$32M
Gross MarginGross profit ÷ Revenue+33.3%+21.3%
Operating MarginEBIT ÷ Revenue+6.2%+9.2%
Net MarginNet income ÷ Revenue-13.0%+7.5%
FCF MarginFCF ÷ Revenue+5.8%+5.2%
Rev. Growth (YoY)Latest quarter vs prior year+4.3%+16.8%
EPS Growth (YoY)Latest quarter vs prior year-14.9%+21.9%
IBEX leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CNXC leads this category, winning 6 of 6 comparable metrics.

On an enterprise value basis, CNXC's 4.8x EV/EBITDA is more attractive than IBEX's 7.8x.

MetricCNXC logoCNXCConcentrix Corpor…IBEX logoIBEXIBEX Limited
Market CapShares × price$1.8B$441M
Enterprise ValueMkt cap + debt − cash$6.1B$496M
Trailing P/EPrice ÷ TTM EPS-1.25x13.88x
Forward P/EPrice ÷ next-FY EPS est.2.17x9.59x
PEG RatioP/E ÷ EPS growth rate0.35x
EV / EBITDAEnterprise value multiple4.84x7.76x
Price / SalesMarket cap ÷ Revenue0.18x0.79x
Price / BookPrice ÷ Book value/share0.58x3.84x
Price / FCFMarket cap ÷ FCF3.13x16.16x
CNXC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

IBEX leads this category, winning 9 of 9 comparable metrics.

IBEX delivers a 31.8% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-33 for CNXC. IBEX carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNXC's 1.69x. On the Piotroski fundamental quality scale (0–9), IBEX scores 7/9 vs CNXC's 5/9, reflecting strong financial health.

MetricCNXC logoCNXCConcentrix Corpor…IBEX logoIBEXIBEX Limited
ROE (TTM)Return on equity-33.2%+31.8%
ROA (TTM)Return on assets-10.8%+16.4%
ROICReturn on invested capital+5.6%+19.5%
ROCEReturn on capital employed+6.6%+22.4%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage1.69x0.52x
Net DebtTotal debt minus cash$4.3B$54M
Cash & Equiv.Liquid assets$327M$15M
Total DebtShort + long-term debt$4.6B$70M
Interest CoverageEBIT ÷ Interest expense-3.07x62.30x
IBEX leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

IBEX leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in IBEX five years ago would be worth $13,650 today (with dividends reinvested), compared to $1,974 for CNXC. Over the past 12 months, IBEX leads with a +29.9% total return vs CNXC's -46.7%. The 3-year compound annual growth rate (CAGR) favors IBEX at 20.6% vs CNXC's -30.0% — a key indicator of consistent wealth creation.

MetricCNXC logoCNXCConcentrix Corpor…IBEX logoIBEXIBEX Limited
YTD ReturnYear-to-date-36.5%-9.8%
1-Year ReturnPast 12 months-46.7%+29.9%
3-Year ReturnCumulative with dividends-65.7%+75.3%
5-Year ReturnCumulative with dividends-80.3%+36.5%
10-Year ReturnCumulative with dividends-61.0%+112.7%
CAGR (3Y)Annualised 3-year return-30.0%+20.6%
IBEX leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

IBEX leads this category, winning 2 of 2 comparable metrics.

IBEX is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than CNXC's 1.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IBEX currently trades 76.2% from its 52-week high vs CNXC's 41.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCNXC logoCNXCConcentrix Corpor…IBEX logoIBEXIBEX Limited
Beta (5Y)Sensitivity to S&P 5001.38x0.80x
52-Week HighHighest price in past year$62.14$42.99
52-Week LowLowest price in past year$22.85$25.00
% of 52W HighCurrent price vs 52-week peak+41.0%+76.2%
RSI (14)Momentum oscillator 0–10036.148.5
Avg Volume (50D)Average daily shares traded1.6M117K
IBEX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CNXC leads this category, winning 1 of 1 comparable metric.

Wall Street rates CNXC as "Buy" and IBEX as "Hold". Consensus price targets imply 104.2% upside for CNXC (target: $52) vs -26.7% for IBEX (target: $24). CNXC is the only dividend payer here at 5.59% yield — a key consideration for income-focused portfolios.

MetricCNXC logoCNXCConcentrix Corpor…IBEX logoIBEXIBEX Limited
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$52.00$24.00
# AnalystsCovering analysts96
Dividend YieldAnnual dividend ÷ price+5.6%
Dividend StreakConsecutive years of raises52
Dividend / ShareAnnual DPS$1.42
Buyback YieldShare repurchases ÷ mkt cap+10.5%+17.7%
CNXC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

IBEX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNXC leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallIBEX Limited (IBEX)Leads 4 of 6 categories
Loading custom metrics...

CNXC vs IBEX: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CNXC or IBEX a better buy right now?

For growth investors, IBEX Limited (IBEX) is the stronger pick with 9.

8% revenue growth year-over-year, versus 2. 2% for Concentrix Corporation (CNXC). IBEX Limited (IBEX) offers the better valuation at 13. 9x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Concentrix Corporation (CNXC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CNXC or IBEX?

On forward P/E, Concentrix Corporation is actually cheaper at 2.

2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CNXC or IBEX?

Over the past 5 years, IBEX Limited (IBEX) delivered a total return of +36.

5%, compared to -80. 3% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: IBEX returned +112. 7% versus CNXC's -61. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CNXC or IBEX?

By beta (market sensitivity over 5 years), IBEX Limited (IBEX) is the lower-risk stock at 0.

80β versus Concentrix Corporation's 1. 38β — meaning CNXC is approximately 73% more volatile than IBEX relative to the S&P 500. On balance sheet safety, IBEX Limited (IBEX) carries a lower debt/equity ratio of 52% versus 169% for Concentrix Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — CNXC or IBEX?

By revenue growth (latest reported year), IBEX Limited (IBEX) is pulling ahead at 9.

8% versus 2. 2% for Concentrix Corporation (CNXC). On earnings-per-share growth, the picture is similar: IBEX Limited grew EPS 28. 3% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CNXC or IBEX?

IBEX Limited (IBEX) is the more profitable company, earning 6.

6% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IBEX leads at 8. 3% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — CNXC leads at 35. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CNXC or IBEX more undervalued right now?

On forward earnings alone, Concentrix Corporation (CNXC) trades at 2.

2x forward P/E versus 9. 6x for IBEX Limited — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 104. 2% to $52. 00.

08

Which pays a better dividend — CNXC or IBEX?

In this comparison, CNXC (5.

6% yield) pays a dividend. IBEX does not pay a meaningful dividend and should not be held primarily for income.

09

Is CNXC or IBEX better for a retirement portfolio?

For long-horizon retirement investors, IBEX Limited (IBEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

80), +112. 7% 10Y return). Both have compounded well over 10 years (IBEX: +112. 7%, CNXC: -61. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CNXC and IBEX?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CNXC is a small-cap income-oriented stock; IBEX is a small-cap deep-value stock. CNXC pays a dividend while IBEX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CNXC

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Gross Margin > 19%
  • Dividend Yield > 2.2%
Run This Screen
Stocks Like

IBEX

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CNXC and IBEX on the metrics below

Revenue Growth>
%
(CNXC: 4.3% · IBEX: 16.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.